Huntington’s disease is a hereditary condition that leads to the progressive degeneration of nerve cells (neurons) in specific areas of the brain. It mainly affects regions that control voluntary ...

Huntington’s disease (HD) is one of those rare conditions that affects not just the patient but the entire family—medically, emotionally and genetically. This inherited brain disorder causes gradual ...

Jagadeesha's brain, the first juvenile Huntington's Disease donation in India, offers hope for vital neurodegenerative ...

Researchers and families unite to address Huntington's disease, exploring innovative therapies and fostering connections at ...

UniQure said the U.S. Food and Drug Administration no longer agreed that clinical data for the Dutch company's gene therapy ...

Scientists have slowed the progression of Huntington’s disease for the first time with a “groundbreaking” new treatment. Experts from University College London (UCL) said the finding could “change ...

A new medical trial showed promising results as scientists seek a breakthrough to treat Huntington's disease, according to research team based in the United Kingdom. The clinical drug trial by ...

The FDA is said to be making a U-turn on uniQure’s one-time gene therapy candidate for Huntington’s disease despite the ...

UCL and uniQure report the first treatment to slow Huntington’s disease with gene therapy AMT-130. High-dose patients had 75% less progression over three years compared with standard care. uniQure ...

The post FDA Feedback Surprises Huntington’s Drug Watchers appeared first on Self Employed.

Eight years later, suffering from frequent falls, involuntary movements, and the inability to eat, Sarah’s grandmother passed away, the cause of death listed as Huntington’s. Sarah’s dad insisted he’d ...